The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 21, 2008
Filed:
Jan. 26, 2005
Applicants:
Isaac J. Rondon, San Francisco, CA (US);
Robert Charles Ladner, Ijamsville, MD (US);
Inventors:
Isaac J. Rondon, San Francisco, CA (US);
Robert Charles Ladner, Ijamsville, MD (US);
Assignee:
Dyax Corp., Cambridge, MA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/00 (2006.01); A61K 38/04 (2006.01); A61K 38/08 (2006.01); A61K 38/10 (2006.01); A61K 38/12 (2006.01); A61K 49/00 (2006.01); A61K 51/08 (2006.01); C07K 4/00 (2006.01); C07K 7/00 (2006.01); C07K 7/04 (2006.01); C07K 9/00 (2006.01); C07K 11/00 (2006.01);
U.S. Cl.
CPC ...
Abstract
The present invention provides binding moieties for CEA, which have a variety of uses wherever detecting, isolating or localizing CEA, and particularly CEA as opposed to cross-reactive antigens such as NCA, is advantageous. Particularly disclosed are synthetic, isolated polypeptides capable of binding CEA, which is overexpressed in adenocarcinomas of endodermally derived digestive system epithelia and fetal colon. Such polypeptides and disclosed derivatives are useful, e.g., as imaging agents for CEA-expressing tumors.